<--- Back to Details
First PageDocument Content
Tick-borne diseases / Medicine / Babesia / Parasites / Vaccine / Shelf life / Abbreviated New Drug Application / Apicomplexa / Biology / Microbiology
Date: 2014-12-10 00:08:33
Tick-borne diseases
Medicine
Babesia
Parasites
Vaccine
Shelf life
Abbreviated New Drug Application
Apicomplexa
Biology
Microbiology

Microsoft Word[removed]doc

Add to Reading List

Source URL: archive.apvma.gov.au

Download Document from Source Website

File Size: 20,59 KB

Share Document on Facebook

Similar Documents

Pharmacokinetics / Pharmaceutical industry / Clinical research / Bioequivalence / Generic drug / Bioavailability / Food and Drug Administration / Clinical trial / Pharmaceutical drug / Abbreviated New Drug Application

Investigator Responsibilities in Protecting Participants in the Conduct of Bioequivalence Studies Cecilia C. Maramba, MD, MScID

DocID: 1ptht - View Document

Food and Drug Administration / Pharmaceuticals policy / Healthcare quality / Prescription Drug User Fee Act / Federal Food /  Drug /  and Cosmetic Act / Abbreviated New Drug Application / Compounding / United States Code / Controlled Substances Penalties Amendments Act / Industrial Hemp Farming Act

PUBLIC LAW 105–115—NOV. 21, 1997 FOOD AND DRUG ADMINISTRATION MODERIZATION ACT OF 1997 111 STAT. 2296

DocID: 1pnIy - View Document

Food and Drug Administration / Pharmaceutical industry / Pharmaceuticals policy / Food law / Abbreviated New Drug Application / New drug application / Federal Food /  Drug /  and Cosmetic Act / Generic drug / Approved Drug Products with Therapeutic Equivalence Evaluations / Center for Drug Evaluation and Research / Drug Master File

Updating ANDA Labeling After the Marketing Application for the Reference Listed Drug Has Been Withdrawn Guidance for Industry

DocID: 1p93k - View Document

Health / Food and Drug Administration / Pharmaceutical industry / Pharmacology / Pharmaceuticals policy / Drug safety / New drug application / Abbreviated New Drug Application / Donepezil / Generic drug / Drug Price Competition and Patent Term Restoration Act / Approved Drug Products with Therapeutic Equivalence Evaluations

Case 2:06-cvHAA-ES Document 71 FiledPage 1 of 45 PageID: 1673 NOT FOR PUBLICATION UNITED STATES DISTRICT COURT

DocID: 1m2hg - View Document

Health / Biotechnology / Patent law / Research exemption / Generic drug / Food and Drug Administration / Abbreviated New Drug Application / Drug Price Competition and Patent Term Restoration Act / Declaratory judgment / Approved Drug Products with Therapeutic Equivalence Evaluations / Novartis

Microsoft Word - 10CV5118 Seattle Childrens Hosp v Akorn MTD.doc

DocID: 1lmCl - View Document